Skip to main content
Elsevier
View Cart
openUserAccount

Books in Neuroscience

Elsevier's Neuroscience collection empowers educators, researchers, and students with actionable knowledge to drive collaborative research and advancements in the field. Content covers the nervous system's intricate workings, covering branches like Affective, Behavioral, and Cognitive neuroscience to investigate the neural basis of emotions, behavior, and cognitive functions. Spanning from Molecular and Cellular Neuroscience to Developmental Neuroscience, content provides insights into brain function in health and disease.

BooksJournals
101-110 of 1771 results in All results

Multiple Sclerosis, An Issue of Neurologic Clinics

  • 1st Edition
  • Volume 42-1
  • November 21, 2023
  • Carrie M. Hersh
  • English
  • Hardback
    9 7 8 - 0 - 3 2 3 - 9 3 9 1 7 - 1
  • eBook
    9 7 8 - 0 - 3 2 3 - 9 3 9 1 8 - 8
In this issue of Neurologic Clinics, guest editor Dr. Carrie M. Hersh brings her considerable expertise to the topic of Multiple Sclerosis. Top experts in the field discuss diagnosis and pathophysiology concepts, treatment, special populations in MS, and contemporary issues related to MS.

Fragile X and Related Autism Spectrum Disorders

  • 1st Edition
  • Volume 173
  • November 17, 2023
  • Michel J. Hurley
  • English
  • Hardback
    9 7 8 - 0 - 4 4 3 - 1 3 7 2 9 - 7
  • eBook
    9 7 8 - 0 - 4 4 3 - 1 3 7 3 0 - 3
Fragile X and Related Autism Spectrum Disorders, Volume 172 in the International Review on Neurobiology series, highlights new advances in the field, with this new volume presenting interesting chapters on The dopamine hypothesis of Autism Spectrum Disorder: a comprehensive analysis of the evidence, A Review of the Use of Psychotropic Medication to Address Challenging Behavior in Neurodevelopmental Disorders, Lipid metabolism alterations in fragile X syndrome and other neurodevelopmental disorders, Genesis, modelling and methodological remedies to autism heterogeneity, Toward an Understanding of the Role of the Exposome on Fragile X Phenotypes, Glial-mediated dysregulation of neurodevelopment in Fragile X Syndrome, and more.

Progress in Motor Control

  • 1st Edition
  • November 17, 2023
  • Mindy F. Levin + 3 more
  • English
  • Paperback
    9 7 8 - 0 - 4 4 3 - 2 3 9 8 7 - 8
  • eBook
    9 7 8 - 0 - 4 4 3 - 2 3 9 8 6 - 1
Progress in Motor Control: From Neuroscience to Patient Outcomes updates the state-of-the-art of knowledge among scientists on basic and applied research on control of movements of biological systems through a clinical perspective. Motor control is a scientific area characterized by multidisciplinary approaches. This book promotes the application of this area into clinical practice. Chapters focus on topics in the field of motor control, including neural control of goal-oriented action, theories on rules of interaction during motor learning, and action coordination up to human and machine interaction.Edited by experts in the field, this book translates current theoretical outcomes into neuroscience and therapeutic solutions.

Vasculitis, An Issue of Neuroimaging Clinics of North America

  • 1st Edition
  • Volume 34-1
  • November 14, 2023
  • Mahmud Mossa-Basha + 2 more
  • English
  • Hardback
    9 7 8 - 0 - 4 4 3 - 1 8 3 4 6 - 1
  • eBook
    9 7 8 - 0 - 4 4 3 - 1 8 3 4 7 - 8
In this issue of Neuroimaging Clinics, guest editors Drs. Mahmud Mossa-Basha, Carlos Zamora, and Mauricio Castillo bring their considerable expertise to the topic of Vasculitis. Both conventional and advanced imaging play a central role in the diagnosis of vasculitides, and in this issue, top experts in the field discuss classification, guidelines, diagnosis, pathology, and imaging of every major type of vasculitis.

Neuromuscular Case Studies

  • 2nd Edition
  • October 27, 2023
  • Tulio E. Bertorini
  • English
  • Paperback
    9 7 8 - 0 - 3 2 3 - 8 7 4 0 0 - 7
  • eBook
    9 7 8 - 0 - 3 2 3 - 8 7 4 3 3 - 5
Ideal for neurologists and other health care professionals who treat patients with neuromuscular diseases, Neuromuscular Case Studies, 2nd Edition, presents more than 100 cases of both common and rare neuromuscular disorders. Dr. Tulio E. Bertorini provides the latest tools and strategies for diagnosis and management that minimize disability and maximize quality of life for your patients, including up-to-date coverage of numerous recent advances in the field. Using a multidisciplinary approach, this practical text contains two parts: the first includes basic aspects of anatomy, physiology, diagnostic tests, and therapeutic strategies; the second describes specific cases and their diagnosis and management. 

Neurotoxicity of Halogenated Organic Compounds

  • 1st Edition
  • Volume 10
  • October 25, 2023
  • Lucio G. Costa + 2 more
  • English
  • Hardback
    9 7 8 - 0 - 4 4 3 - 1 3 3 4 0 - 4
  • eBook
    9 7 8 - 0 - 4 4 3 - 1 3 3 4 1 - 1
Neurotoxicity of Halogenated Organic Compounds, Volume 10 covers three groups of Halogenated Organic Compounds (Chlorinated, Brominated, and Fluorinated Compounds) that are legacy and emerging contaminants, providing background information, characteristics, physicochemical properties, environmental contamination, and human exposure. Specific chapters covered in this release include Perspective on Halogenated Organic Compounds, The Neurotoxicity of Polychlorinated Biphenyls (PCBs), Neuroendocrine Effects of Polychlorinated Biphenyls (PCBs), Mechanisms of PCB Neurotoxicity: AHR and THR Dogma meet RYR reality, Microbiome and the Neurotoxicity of Brominated Flame Retardants (BFRs), and much more. Other chapters cover Neuroendocrine Effects of Brominated Flame Retardants (BFRs), Focused on Polybrominated Diphenyl Ethers (PBDEs), Neurochemical Effects of Halogenated Organic Compounds: Possible Mode(s) of action and Structure-Activity Relationships, The Neurotoxic Effects of Perfluoroalkyl Substances (PFAS) in Animal Models and Human Cohorts, Neurochemical Mechanisms of Perfluoroalkyl Substances (PFAS) Neurotoxic Action, and Future Directions and Regulatory aspects of Halogenated Organic Compounds.

Nanowired Delivery of Drugs and Antibodies for Neuroprotection in Brain Diseases with Co-Morbidity Factors Part B

  • 1st Edition
  • Volume 172
  • October 11, 2023
  • Hari Shanker Sharma + 2 more
  • English
  • Hardback
    9 7 8 - 0 - 4 4 3 - 2 9 4 6 8 - 6
  • eBook
    9 7 8 - 0 - 4 4 3 - 2 9 4 6 9 - 3
Nanowired Delivery of Drugs and Antibodies for Neuroprotection in Brain Diseases with Co-morbidity Factors, Part B, Volume 172 in the International Review of Neurobiology series, includes chapters on Spinal cord injury induced exacerbation of Alzheimer's disease pathophysiology in the cord is reduced by topical application of nanowired cerebrolysin and antibodies to tumor necrosis factor alpha, Nanodelivery of histamine H3 receptor inverse agonist BF-2549 with clobenpropit a H3 receptor antagonist and H4 receptor agonist induced neuroprotection in spinal cord injury is potentiated by antioxidant compound H-290/51, and Neuromodulation and quality of life for patient with spasticity after spinal cord injury, and more.Other sections cover Efficacy of invasive and non-invasive methods for the treatment of Parkinson´s disease: nanodelivery and enriched environment, Co-administration of DL-3-n-butylphthalide and neprilysin is neuroprotective in Alzheimer disease associated with brain injury, Nicotine Neurotoxicity Exacerbation following Engineered Ag and Cu (50-60 nm) nanoparticles intoxication, and Neuroprotection with nanowired delivery of antioxidant compound H-290/51 together with serotonin 5-HT3 receptor antagonist ondansetron.

Functional Neurological Disorder, An Issue of Neurologic Clinics

  • 1st Edition
  • Volume 41-4
  • October 3, 2023
  • David Perez + 1 more
  • English
  • Hardback
    9 7 8 - 0 - 3 2 3 - 9 3 8 3 9 - 6
  • eBook
    9 7 8 - 0 - 3 2 3 - 9 3 8 4 0 - 2
In this issue of Neurologic Clinics, guest editosr Drs. David L. Perez and Sara A. Finkelstein bring their considerable expertise to the topic of Functional Neurologic Disorders. Top experts in the field cover issues such as functional movement disorder: assessment and treatment; functional cognitive disorder: diagnosis, treatment, and differentiation from secondary causes of cognitive dysfunction; functional speech and voice disorders: diagnosis and treatment; personalizing clinical care in functional neurological disorder: a biopsychosocial-informed perspective; and more. 

Nanowired Delivery of Drugs and Antibodies for Neuroprotection in Brain Diseases with Co-morbidity Factors Part A

  • 1st Edition
  • Volume 171
  • September 26, 2023
  • Hari Shanker Sharma + 2 more
  • English
  • eBook
    9 7 8 - 0 - 3 2 3 - 9 9 7 7 8 - 2
Nanowired Delivery of Drugs and Antibodies for Neuroprotection in Brain Diseases with Co-morbidity Factors, Volume 171 in the International Review of Neurobiology series, highlights new advances in the field with this new volume presenting interesting chapters on Neurodegenerative diseases, Stress induced exacerbation of Alzheimer's disease brain pathology is thwarted by co-administration of nanowired cerebrolysin and amyloid beta peptide antibodies with serotonin 5-HT6 receptor antagonist SB-39988, Nanowired delivery of dl-3-n-butylphthalide with antibodies to alpha synuclein potentiated neuroprotection in Parkinson's disease with emotional stress, Efficacy of invasive and non-invasive methods for the treatment of Parkinson´s disease: nanodelivery and enriched environment, and much more. Other sections cover Sleep deprivation induced exacerbation of Parkinson's disease pathophysiology is attenuated by co-administration of nanowired cerebrolysin and serotonin-3 receptor antagonist ondansetron, Co-administration of DL-3-n-butylphthalide and neprilysin is neuroprotective in Alzheimer disease associated with brain injury, Stress and brain diseases, Pathophysiology of sleep deprivation enhances amyloid beta peptide and p-tau in the CSF and brain, Neuroprotective effects of nanowired delivery of multimodal drug cerebrolysin and monoclonal 5-HT antibodies, Prior heat exposure exacerbates brain blast injury, Neuroprotection by nanodelivery of cerebrolysin with serotonin 6 receptor antagonist SB-399885, the Effects of curcumin nanodelivery on several brain pathologies, and more.

Treatment-Resistant Depression Part B

  • 1st Edition
  • Volume 281
  • September 26, 2023
  • Chih-Ming Cheng + 1 more
  • English
  • Hardback
    9 7 8 - 0 - 4 4 3 - 2 2 3 9 4 - 5
  • eBook
    9 7 8 - 0 - 4 4 3 - 2 2 3 9 5 - 2
Treatment-Resistant Depression, Part B, Volume 281 in the Progress in Brain Research series, highlights new advances in the field, with this new volume presenting interesting chapters on highly relevant topics such as Treatment Resistant Depression in Children and Adolescents, Treatment Resistant Depression in Elderly, Brain Stimulation for Treatment Resistant Depression, Electroconvulsive Therapy for Treatment Resistant Depression, Psychological aspects and Psychotherapy for Treatment Resistant Depression, Psychiatric Rehabilitation and Cognitive Deficit for Treatment-Resistant Depression, Insomnia and Treatment Resistant Depression, and Tinnitus and Treatment Resistant Depression.

Related subjects

Behavioral neuroscience

Cognitive neuroscience

Developmental neuroscience and regeneration

Molecular neuroscience

Neural aging

Neuroanatomy

Neurobiology

Neurochemistry

Neuroendocrinology

Neurogenetics

Neuroimmunology

Neurology

Neuropathology

Neuropharmacology

Neurophysiology

Neuroscience general

Neuroscience methodology

Neurotoxicology

Sensory systems